Package 63868-485-50

{"route": ["ORAL"], "spl_id": "db6c7572-59e0-4734-bfd6-1117dad5dd1b", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "upc": ["0635515946132"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["4005f8dd-3050-4590-8703-6997444e8df3"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-485-01)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "63868-485-01", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-485-24)  / 24 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "63868-485-24", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}, {"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (63868-485-50)  / 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "63868-485-50", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}], "brand_name": "Headache Relief Extra Strength", "product_id": "63868-485_db6c7572-59e0-4734-bfd6-1117dad5dd1b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63868-485", "generic_name": "Acetaminophen, Aspirin and caffeine", "labeler_name": "CHAIN DRUG MARKETING ASSOCIATION INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Headache Relief", "brand_name_suffix": "Extra Strength", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20270331", "marketing_start_date": "19921117"}